+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Livestock Gut Health Solutions Market by Animal Type (Aquaculture, Poultry, Ruminants), Product Type (Enzymes, Organic Acids, Phytogenics), Application, Form, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129655
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Unlocking the Strategic Foundations of Livestock Gut Health to Enhance Animal Wellbeing, Optimize Nutrition, and Propel Farm Productivity

Livestock production is increasingly challenged by the need to balance animal welfare, sustainable practices, and efficient nutrition utilization. Healthy gastrointestinal systems are recognized as the cornerstone of robust immune function and optimal nutrient absorption. In recent years, intensifying scrutiny over antibiotic usage has prompted stakeholders across the production chain to seek alternative gut health strategies that support both productivity and regulatory compliance. Accordingly, the concept of gut health has evolved from a mere focus on performance enhancement to a comprehensive framework encompassing microbial balance, intestinal integrity, and systemic health.

This introduction delineates the critical landscape in which gut health solutions have emerged as a strategic imperative for producers and feed formulators alike. Advances in our understanding of the microbiome’s interaction with host physiology have unlocked novel approaches to modulate intestinal function. These approaches range from tailored feed additives that target specific pathogens to integrative formulations designed to reinforce barrier function and mitigate oxidative stress. As a result, decision makers are increasingly integrating science-driven protocols into herd and flock management programs.

Looking ahead, the imperative to integrate gut health into broader herd management strategies aligns with global sustainability goals and corporate environmental commitments. Producers are increasingly incorporating waste reduction metrics and carbon footprint assessments into gut health programming, recognizing that enhanced feed efficiency translates to lower resource consumption and reduced greenhouse gas emissions. This holistic approach positions gut health solutions as a lever for both animal health and environmental stewardship, creating a compelling value proposition for stakeholders at every stage of the supply chain.

This executive summary synthesizes the most impactful trends shaping the livestock gut health sector. It examines the transformative shifts in product innovation, regulatory dynamics, and evolving distribution models. Additionally, it provides an analysis of the implications of recent United States tariff measures, outlines critical segmentation insights, and offers regional and competitive perspectives. By concluding with actionable recommendations and a transparent research methodology, this summary equips industry leaders with the strategic context necessary to capitalize on emerging opportunities and navigate ongoing challenges.

Embracing the Emergence of Innovative Gut Modulation Strategies Amid Regulatory Evolution and Amplified Animal Welfare Expectations

Livestock gut health is at the crossroads of several transformative forces that are redefining production paradigms. The global mandate to reduce antibiotic growth promoters has accelerated the adoption of non-antibiotic feed additives, driving innovation in organic acids, phytogenics, and targeted enzyme supplementation. Simultaneously, heightened consumer awareness regarding animal welfare has elevated the importance of robust intestinal integrity and microbiome diversity, encouraging producers to embrace more holistic and preventive health measures. In parallel, regulatory bodies are instituting stringent guidelines that reward transparency in feed formulation and penalize indiscriminate antimicrobial use, thereby reshaping the product development roadmap for gut health solutions.

Technological advancements have further enriched this landscape by enabling precision nutrition strategies that leverage real-time data capture from on-farm sensors and performance metrics. These insights inform dynamic formulation adjustments that optimize microbial profiles while minimizing nutrient waste. Moreover, the integration of omics technologies-such as metagenomics and metabolomics-has provided unprecedented clarity into the specific microbial taxa and metabolic pathways that underpin gut function. This scientific depth is fueling the design of next-generation prebiotic-probiotic synergies that target pathogen suppression, enhance immune modulation, and improve feed conversion ratios in a quantifiable manner.

Geopolitical considerations are also influencing regulatory frameworks and investment flows. For instance, the European Union’s prohibition of certain antibiotic growth promoters has served as a catalyst for wider adoption of non-antibiotic additives, while the United States FDA’s emphasis on veterinary feed directives has encouraged the development of more stringent usage protocols. In Asia, evolving national standards aligned with Codex Alimentarius guidelines are fostering cross-border harmonization of feed additive approvals. These regulatory trajectories not only stimulate product differentiation but also underpin the emergence of digital traceability platforms that track additive provenance and usage patterns from feed mill to animal barn.

At the consumer level, digital platforms and blockchain technologies are being piloted to provide end-to-end traceability, reinforcing brand reputation and price premiums for antibiotic-free and sustainably produced protein. Consequently, feed and additive suppliers must navigate a multi-dimensional landscape that couples scientific rigor with supply chain transparency and digital engagement strategies.

Analyzing the Far Reaching Consequences of Newly Implemented United States Tariff Adjustments on Ingredient Sourcing and Cost Structures

Beginning in early 2025, a slate of revised United States tariffs on key feed additive components has introduced new complexities into global supply chains. Ingredients such as select organic acids, specialty enzymes, and microbial fermentation by-products have become subject to adjusted duty rates, elevating the landed cost of these critical inputs. This shift has prompted formulating experts to reexamine sourcing strategies, balancing the imperative to maintain product efficacy with the need to preserve margin stability. As import costs rise, producers and suppliers are exploring alternative procurement channels and domestic production partnerships to secure reliable ingredient streams.

These tariff modifications have had a ripple effect throughout commercial pricing structures. Ingredient manufacturers have confronted pressure to optimize their operational efficiencies and renegotiate contracts to mitigate the impact on downstream stakeholders. In parallel, feed mills and integrators are conducting cost-benefit analyses to determine the viability of reformulating existing blends. Some have prioritized higher-margin solutions that offer robust performance at adjusted price points, while others have leveraged localized supply agreements to circumvent tariff exposures altogether. The dynamic interplay between tariff policy and supply chain adaptation underscores the strategic importance of agility in sourcing.

The tariff-driven cost pressures have driven parallel interest in alternative ingredient classes that can deliver comparable performance at lower tariff brackets. For example, some formulators are evaluating plant-derived organic acids that fall under preferential trade agreements, while others are accelerating the adoption of in situ enzyme production through on-site bioreactors. These adaptations reflect a strategic shift toward ingredient diversification, where reliance on a single input source is replaced by a dynamic portfolio that balances efficacy with trade resilience.

In addition to cost implications, the tariff measures have prompted a renewed focus on supply chain transparency and partnership alignment. Stakeholders are instituting more rigorous supplier auditing protocols and developing collaborative inventory management systems to forecast ingredient demand with greater precision. This proactive stance not only mitigates the immediate financial impacts of tariff fluctuations but also fosters stronger supplier relationships based on shared risk management and long-term planning.

Collectively, these responses underscore the importance of agility and innovation in navigating policy-induced disruptions. Companies that successfully reengineer their supply chains will be better positioned to absorb future trade headwinds while maintaining the consistent product performance required by producers and veterinarians.

Decoding Segmentation Insights Revealing Demand Drivers across Livestock Animal Types Product Innovations Application Forms and Distribution Channels

Comprehensive segmentation analysis reveals nuanced demand patterns that guide targeted solution development. The categorization by animal type underscores the distinct needs of Aquaculture operations focusing on both Fish and Shrimp, Poultry systems comprised of Broilers, Layers, and Turkey populations, Ruminant enterprises encompassing Beef Cattle, Dairy Cattle, and Sheep and Goat herds, as well as Swine production cycles featuring Grower Finisher Pigs, Sows and Boars, and Weaner Piglets. Each subgroup presents unique gastrointestinal profiles and risk factors, necessitating tailored gut health programs that address species-specific digestive physiology and microbial ecosystems.

Within Aquaculture, gut health solutions are calibrated to mitigate challenges associated with high-density farming and water quality fluctuations, emphasizing immune support during early lifecycle stages. Poultry operators often prioritize rapid gut maturation in broilers to maximize feed conversion over short production cycles, whereas layer and turkey segment specifications focus on controlling dysbiosis and optimizing nutrient partitioning for sustained egg production and meat yield. In ruminants, the interplay between rumen fermentation and hindgut health necessitates dual-mode additives that support both fiber digestion and post-rumen microbial balance. Swine producers, facing weaning stress and gastrointestinal inflammation, increasingly turn to synergistic combinations of organic acids and probiotic strains.

Equally critical is the product type segmentation, which spans Enzymes designed to augment feed digestibility, Organic Acids such as Acetic, Formic, and Propionic Acid that lower gastrointestinal pH and inhibit pathogenic growth, Phytogenics offering plant-derived bioactive compounds, Prebiotics including Fructo Oligosaccharides, Galacto Oligosaccharides, and Mannan Oligosaccharides that selectively nourish beneficial microbes, and Probiotics delivered as Bacterial Probiotics-principally Bifidobacterium and Lactobacillus strains-or Yeast Probiotics. The interplay between these categories shapes formulation strategies that optimize microbiome balance and nutrient uptake.

Application-based segmentation further delineates targeted interventions into Disease Prevention protocols emphasizing Prophylactic Use and Vaccination Support, Growth Promotion strategies that enhance feed conversion efficiency, and Therapeutic Treatment approaches addressing Enteritis Treatment and Post Antimicrobial Recovery. Form considerations highlight the deployment of Feed Additives, Feed Materials, and Water Additives to align with on-farm handling practices and dosage precision. Finally, distribution channels range from Direct Sales and Distributors to E Commerce platforms and Veterinary Clinics, each presenting unique service models, support infrastructures, and customer engagement dynamics that influence solution penetration and sustained adoption.

Exploring Divergent Regional Dynamics Influencing Livestock Gut Health Adoption across the Americas Europe Middle East Africa and Asia Pacific

Demand in the Americas is characterized by mature production systems that prioritize efficacious gut health solutions to sustain high-throughput operations. Producers in the United States, Canada, and key South American markets are rapidly integrating scientifically validated feed additives to comply with tightening regulations on antimicrobial use and to respond to consumer preferences for traceable, responsibly produced protein. Brazil’s rapidly expanding poultry and swine industries are integrating gut health programs to drive export competitiveness, particularly in markets with stringent residue monitoring. Canada’s emphasis on zero tolerance for antibiotic residues has stimulated collaborative research between feed companies and government agencies. Mexico’s nascent feed additive sector is rapidly scaling local distribution networks to serve decentralized pork and poultry farms. These regional nuances highlight the importance of aligning product portfolios with localized regulatory and production imperatives.

Europe, the Middle East, and Africa present a mosaic of regulatory frameworks and production scale. In Western Europe, stringent antibiotic restrictions and a strong regulatory emphasis on animal welfare have catalyzed demand for innovative prebiotic and probiotic blends. Meanwhile, Middle Eastern and African stakeholders are focused on cost-effective solutions that can withstand variable feed supply quality and environmental stressors. Key initiatives such as the African Union’s harmonization of veterinary standards and the Gulf Cooperation Council’s feed additive guidelines are contributing to broader market integration. The European Green Deal’s Farm to Fork strategy further underscores the strategic significance of gut health in achieving overarching sustainability targets, incentivizing suppliers to innovate with low-carbon, natural additive solutions. However, challenges in infrastructure and cold chain logistics in certain African markets present opportunities for modular, climate-adapted formulations that maintain stability under variable conditions.

Asia-Pacific markets exhibit accelerated growth dynamics fueled by expanding aquaculture and intensive poultry sectors. Countries such as China, India, and Australia are witnessing rising adoption of gut health programs that address region-specific challenges like heat stress and feed ingredient variability. In Southeast Asia, smallholder farms in Vietnam and Thailand are embracing community-based extension programs that educate producers on gut health management. In Australia and New Zealand, large-scale dairy and beef operations are partnering with technology firms to deploy integrated herd health platforms. Meanwhile, India’s regulatory evolution, including recent notifications on feed additive registration, is streamlining product approval processes, enabling faster market entry for innovative solutions. Regulatory modernization in several Asia-Pacific nations is harmonizing standards with international best practices, enabling smoother cross-border collaboration and technology transfer.

Examining Strategic Moves and Innovational Trajectories of Leading Stakeholders Driving Growth in Livestock Gut Health Solutions

Leading stakeholders in the livestock gut health arena are deploying a range of strategic initiatives that emphasize innovation, M&A activity, and collaborative partnerships. A cohort of specialized additive manufacturers has intensified research into proprietary bacterial strains, enzyme complexes, and phytogenic blends to differentiate their portfolios. Simultaneously, organizations with integrated feed and health divisions are leveraging cross-functional expertise to co-develop end-to-end solutions that streamline customer adoption and generate holistic performance data. This convergence of R&D and commercial capabilities is setting new benchmarks for product efficacy and customer support services.

Leading chemical and feed additive conglomerates are accelerating their innovation pipelines through dedicated research centers focused on gut health microbiome science. Several organizations have launched proprietary testing services that enable on-site gut health diagnostics and tailored additive recommendations. Others are expanding their footprint through bolt-on acquisitions of specialized biotech startups, thereby augmenting their microbial strain libraries and fermentation capabilities.

Emerging competitors are also leveraging open innovation models, such as crowdsourcing challenges and academic partnerships, to accelerate discovery of novel bioactives. Collaboration with universities has yielded breakthroughs in enzyme engineering, including heat-stable variants that withstand pelleting processes. In parallel, strategic joint ventures between regional distributors and global producers are optimizing last-mile delivery and technical support, particularly in emerging economies. These two-pronged approaches-combining top-down resource investment with grassroots innovation-are shaping a competitive ecosystem where agility and scientific depth differentiate market leaders.

Implementing Proactive Strategies and Collaborative Frameworks to Elevate Efficacy and Sustainability in Livestock Gut Health Management

Industry leaders should proactively adopt integrated gut health frameworks that combine feed additive innovation with digital monitoring and data analytics. By implementing precision nutrition protocols informed by real-time animal performance metrics, producers can optimize microbial balance while reducing feed wastage and minimizing reliance on traditional antibiotics. Establishing cross-disciplinary teams that include nutritionists, veterinarians, and data scientists will facilitate the rapid translation of research insights into on-farm best practices. Furthermore, forging strategic partnerships with ingredient manufacturers and technology providers can accelerate the co-development of tailored solutions that address species-specific and region-specific challenges.

To capitalize on these developments, industry participants are advised to establish multidisciplinary gut health councils that integrate feed formulation, veterinary practice, and data analytics. These councils can facilitate cross-functional knowledge sharing, accelerate product iteration cycles, and ensure alignment with evolving regulatory requirements. Companies should also pilot digital platforms that capture farm-level performance metrics, enabling continuous refinement of additive formulations and dosage protocols based on real-world efficacy data.

Moreover, diversification of ingredient portfolios is essential. Stakeholders should assess emerging bioactive classes, such as marine-derived peptides and microalgae extracts, for complementary benefits. Investment in encapsulation and delivery technologies can further enhance additive stability and targeted release. At the same time, implementing supplier scorecards that evaluate quality, compliance, and sustainability practices will fortify supply chain integrity. Engaging proactively with regulatory authorities through scientific advisory committees can help shape outcome-focused standards and expedite approval pathways.

Outlining the Robust Multistage Research Approach Integrating Qualitative Insights Primary Intelligence and Comprehensive Secondary Analysis

A rigorous research approach underpins the insights presented in this executive summary. Primary qualitative data were collected through in-depth interviews with industry executives, animal nutrition specialists, and regulatory experts across major production regions. These interviews provided firsthand perspectives on operational challenges, emerging preferences, and technology adoption barriers. Secondary data sources included peer-reviewed scientific publications, white papers from leading academic and industry research centers, and publicly available regulatory documentation, ensuring a comprehensive understanding of the evolving policy landscape.

Quantitative validation was achieved by triangulating identified trends with proprietary databases tracking ingredient registration filings, patent activity, and production volume metrics. This multi-source corroboration enabled the identification of high-impact innovations and credible growth vectors without reliance on proprietary forecasting models. The integration of geospatial analysis illuminated regional supply chain configurations and highlighted opportunities for localization and risk mitigation. Throughout the process, each insight was subjected to peer review by subject matter experts to ensure analytical rigor and relevance.

The research framework also incorporated geospatial cluster analysis to map production hotspots and identify correlation patterns between regional feed additive adoption and disease prevalence. Advanced text mining of patent filings uncovered emerging traction in specific strain combinations and encapsulation technologies. To ensure high data fidelity, outlier analysis was conducted to validate consistency across disparate data sets, with outlier handling protocols documented in an appendix. Confidentiality agreements were secured with participating firms to enable disclosure of proprietary adoption metrics without attribution.

Limitations have been acknowledged transparently, such as potential bias in self-reported efficacy data and the evolving nature of regulatory schedules that may shift parameters post-analysis. Mitigation measures included cross-verification with independent veterinary records and consultation with regulatory affairs specialists to anticipate policy trajectories. Overall, the methodological rigor balances proprietary access with reproducibility, delivering insights that stakeholders can trust for strategic planning and competitive benchmarking.

Synthesizing Key Observations and Strategic Imperatives to Foster Future Resilience and Growth in Livestock Gut Health Solutions

As livestock production systems become increasingly complex, maintaining optimal gut health has emerged as a central determinant of animal performance, regulatory compliance, and consumer acceptance. The convergence of stringent antibiotic regulations, shifting consumption patterns, and technological advancements has created a dynamic environment in which gut health solutions must continuously evolve. Segmentation analysis has underscored the importance of tailoring interventions to specific animal types, product modalities, applications, and distribution channels, while regional insights have highlighted the divergent drivers across the Americas, EMEA, and Asia-Pacific.

As a result of these converging trends, the gut health landscape is poised for accelerated innovation cycles that will redefine product portfolios and delivery models. Stakeholders that harness the full spectrum of segmentation insights, regional dynamics, and competitive intelligence will be better equipped to deliver differentiated solutions. Embracing methodological transparency and collaborative industry initiatives will further strengthen the sector’s capacity to address global protein demand sustainably. The imperative now is to translate these insights into concrete action plans that drive measurable health and productivity outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Animal Type
    • Aquaculture
      • Fish
      • Shrimp
    • Poultry
      • Broilers
      • Layers
      • Turkey
    • Ruminants
      • Beef Cattle
      • Dairy Cattle
      • Sheep And Goat
    • Swine
      • Grower Finisher Pigs
      • Sows And Boars
      • Weaner Piglets
  • Product Type
    • Enzymes
    • Organic Acids
      • Acetic Acid
      • Formic Acid
      • Propionic Acid
    • Phytogenics
    • Prebiotics
      • Fructo Oligosaccharides
      • Galacto Oligosaccharides
      • Mannan Oligosaccharides
    • Probiotics
      • Bacterial Probiotics
        • Bifidobacterium
        • Lactobacillus
      • Yeast Probiotics
  • Application
    • Disease Prevention
      • Prophylactic Use
      • Vaccination Support
    • Growth Promotion
    • Therapeutic Treatment
      • Enteritis Treatment
      • Post Antimicrobial Recovery
  • Form
    • Feed Additive
    • Feed Material
    • Water Additive
  • Distribution Channel
    • Direct Sales
    • Distributors
    • E Commerce
    • Veterinary Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Cargill, Incorporated
  • Royal DSM N.V.
  • Evonik Industries AG
  • BASF SE
  • Alltech, Inc.
  • Kemin Industries, Inc.
  • Nutreco N.V.
  • Adisseo SA
  • Novus International, Inc.
  • Phibro Animal Health Corporation

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of precision microbiome modulation strategies to optimize livestock gut health
5.2. Integration of advanced feed enzyme technologies to enhance nutrient utilization and gut integrity in livestock
5.3. Rising demand for antibiotic-free production driving alternatives like probiotics and phytogenics in animal diets
5.4. Expansion of digital gut health monitoring platforms enabling real-time data for targeted nutritional interventions
5.5. Emergence of encapsulated delivery systems to protect and release gut health additives in lower digestive tract
5.6. Focus on reducing environmental emissions through gut-targeted feed solutions that improve feed conversion rates
5.7. Growing interest in genomic and metagenomic tools to tailor gut health strategies to specific livestock breeds
5.8. Increasing collaboration between feed additive producers and research institutes to accelerate gut health innovation
5.9. Shift towards sustainable feed ingredients like insect meal and algae supplements to support microbiome health
5.10. Regulatory reforms in major markets leading to stricter evaluation of gut health claims for livestock additives
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Livestock Gut Health Solutions Market, by Animal Type
8.1. Introduction
8.2. Aquaculture
8.2.1. Fish
8.2.2. Shrimp
8.3. Poultry
8.3.1. Broilers
8.3.2. Layers
8.3.3. Turkey
8.4. Ruminants
8.4.1. Beef Cattle
8.4.2. Dairy Cattle
8.4.3. Sheep And Goat
8.5. Swine
8.5.1. Grower Finisher Pigs
8.5.2. Sows And Boars
8.5.3. Weaner Piglets
9. Livestock Gut Health Solutions Market, by Product Type
9.1. Introduction
9.2. Enzymes
9.3. Organic Acids
9.3.1. Acetic Acid
9.3.2. Formic Acid
9.3.3. Propionic Acid
9.4. Phytogenics
9.5. Prebiotics
9.5.1. Fructo Oligosaccharides
9.5.2. Galacto Oligosaccharides
9.5.3. Mannan Oligosaccharides
9.6. Probiotics
9.6.1. Bacterial Probiotics
9.6.1.1. Bifidobacterium
9.6.1.2. Lactobacillus
9.6.2. Yeast Probiotics
10. Livestock Gut Health Solutions Market, by Application
10.1. Introduction
10.2. Disease Prevention
10.2.1. Prophylactic Use
10.2.2. Vaccination Support
10.3. Growth Promotion
10.4. Therapeutic Treatment
10.4.1. Enteritis Treatment
10.4.2. Post Antimicrobial Recovery
11. Livestock Gut Health Solutions Market, by Form
11.1. Introduction
11.2. Feed Additive
11.3. Feed Material
11.4. Water Additive
12. Livestock Gut Health Solutions Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. E Commerce
12.5. Veterinary Clinics
13. Americas Livestock Gut Health Solutions Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Livestock Gut Health Solutions Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Livestock Gut Health Solutions Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Cargill, Incorporated
16.3.2. Royal DSM N.V.
16.3.3. Evonik Industries AG
16.3.4. BASF SE
16.3.5. Alltech, Inc.
16.3.6. Kemin Industries, Inc.
16.3.7. Nutreco N.V.
16.3.8. Adisseo SA
16.3.9. Novus International, Inc.
16.3.10. Phibro Animal Health Corporation
17. ResearchAI18. ResearchStatistics19. ResearchContacts20. ResearchArticles21. Appendix
List of Figures
FIGURE 1. LIVESTOCK GUT HEALTH SOLUTIONS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. LIVESTOCK GUT HEALTH SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. LIVESTOCK GUT HEALTH SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. LIVESTOCK GUT HEALTH SOLUTIONS MARKET: RESEARCHAI
FIGURE 26. LIVESTOCK GUT HEALTH SOLUTIONS MARKET: RESEARCHSTATISTICS
FIGURE 27. LIVESTOCK GUT HEALTH SOLUTIONS MARKET: RESEARCHCONTACTS
FIGURE 28. LIVESTOCK GUT HEALTH SOLUTIONS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LIVESTOCK GUT HEALTH SOLUTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SHRIMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SHRIMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BROILERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BROILERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY LAYERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY LAYERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY TURKEY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY TURKEY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BEEF CATTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SHEEP AND GOAT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SHEEP AND GOAT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY GROWER FINISHER PIGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY GROWER FINISHER PIGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SOWS AND BOARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SOWS AND BOARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY WEANER PIGLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY WEANER PIGLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ACETIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ACETIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORMIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORMIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROPIONIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROPIONIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PHYTOGENICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PHYTOGENICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY YEAST PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY YEAST PROBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROPHYLACTIC USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROPHYLACTIC USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY VACCINATION SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY VACCINATION SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ENTERITIS TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ENTERITIS TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POST ANTIMICROBIAL RECOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POST ANTIMICROBIAL RECOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FEED MATERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FEED MATERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY WATER ADDITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY WATER ADDITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY E COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 191. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 192. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 193. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 194. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 195. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 196. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 197. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2018-2024 (USD MILLION)
TABLE 198. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2025-2030 (USD MILLION)
TABLE 199. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2018-2024 (USD MILLION)
TABLE 200. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2025-2030 (USD MILLION)
TABLE 201. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2018-2024 (USD MILLION)
TABLE 204. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2025-2030 (USD MILLION)
TABLE 205. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 206. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 207. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 208. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 209. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 210. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 211. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2018-2024 (USD MILLION)
TABLE 214. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2025-2030 (USD MILLION)
TABLE 215. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2018-2024 (USD MILLION)
TABLE 216. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2025-2030 (USD MILLION)
TABLE 217. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 218. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 219. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. CANADA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 222. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 223. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 224. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 225. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 226. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 227. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2018-2024 (USD MILLION)
TABLE 228. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2025-2030 (USD MILLION)
TABLE 229. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2018-2024 (USD MILLION)
TABLE 230. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2025-2030 (USD MILLION)
TABLE 231. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2018-2024 (USD MILLION)
TABLE 234. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2025-2030 (USD MILLION)
TABLE 235. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 238. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 239. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 240. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 241. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2018-2024 (USD MILLION)
TABLE 244. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2025-2030 (USD MILLION)
TABLE 245. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2018-2024 (USD MILLION)
TABLE 246. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2025-2030 (USD MILLION)
TABLE 247. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 248. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 249. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. MEXICO LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY AQUACULTURE, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY POULTRY, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY RUMINANTS, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY SWINE, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY ORGANIC ACIDS, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY BACTERIAL PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY DISEASE PREVENTION, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA LIVESTOCK GUT HEALTH SOLUTIONS MARKET SIZE, BY THERAPEUTIC TREATMENT, 2025-2030 (USD MILLION)
TABLE 307. AR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Livestock Gut Health Solutions Market report include:
  • Cargill, Incorporated
  • Royal DSM N.V.
  • Evonik Industries AG
  • BASF SE
  • Alltech, Inc.
  • Kemin Industries, Inc.
  • Nutreco N.V.
  • Adisseo SA
  • Novus International, Inc.
  • Phibro Animal Health Corporation